Civil settlements with Pfizer and Wyeth, which Pfizer acquired in 2009, amount to a $45 million disgorgement of profits. Pfizer agreed to pay more than $26.3 million while Wyeth agreed to $18.8 million. The government claimed Pfizer made a range of improper payments to officials — including hospital administrators, members of regulatory committees and healthcare professionals — in Bulgaria, Croatia, Kazakhstan and Russia to influence Pfizer product approval and sales.
Pfizer H.C.P. Corporation, a wholly-owned subsidiary of Pfizer, also agreed to pay $15 million in penalties. The subsidiary admitted that between 1997 and 2006, it paid more than $2 million in bribes to government officials in Bulgaria, Croatia, Kazakhstan and Russia. Pfizer H.C.P. also admitted that it made more than $7 million in profits as a result of those bribes.
More Articles on Pharmaceutical Fraud:
Largest Healthcare Settlement in U.S. History: GlaxoSmithKline to Pay $3B
Abbott to Pay $1.5B Settlement for Off-Label Marketing of Depakote
Johnson & Johnson Slapped With $1.1B Fine for Risperdal Marketing
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
